Bulletin
Investor Alert

ICU Medical Inc.

NAS: ICUI

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Dec 6, 2021, 4:12 p.m.

/zigman2/quotes/208026181/composite

$

224.16

Change

0.00 0.00%

Volume

Volume 4,155

Quotes are delayed by 20 min

/zigman2/quotes/208026181/composite

Previous close

$ 220.96

$ 224.16

Change

+3.20 +1.45%

Day low

Day high

$219.50

$225.96

Open

52 week low

52 week high

$183.39

$282.00

Open

Thomas D. McCall

Currently, Thomas D. McCall holds the position of VP-Marketing & Communications, GM-Critical Care at ICU Medical, Inc.

In the past he occupied the position of VP-Marketing Communications & Brand Strategy at Masimo Corp. and VP-Corporate Marketing & Brand Development at Welch Allyn, Inc.

Transactions

Date Shares Transaction Value
01/17/2020 1,698   Derivative/Non-derivative trans. at $0 per share. 0
01/17/2020 3,153   Derivative/Non-derivative trans. at $0 per share. 0
03/27/2019 174   Derivative/Non-derivative trans. at $0 per share. 0
03/27/2019 350   Derivative/Non-derivative trans. at $0 per share. 0
03/06/2019 2,791   Derivative/Non-derivative trans. at $0 per share. 0
03/06/2019 6,111   Derivative/Non-derivative trans. at $0 per share. 0
02/15/2019 149   Derivative/Non-derivative trans. at $0 per share. 0
02/15/2019 429   Derivative/Non-derivative trans. at $0 per share. 0
02/05/2019 679   Derivative/Non-derivative trans. at $0 per share. 0
02/05/2019 260   Derivative/Non-derivative trans. at $0 per share. 0
08/24/2018 2,901   Disposition at $303.45 per share. 880,309
08/24/2018 6,633   Disposition at $302.7 per share. 2,007,810
08/24/2018 2,142   125,928
08/24/2018 7,392   656,113
08/23/2018 209   12,623
08/23/2018 563   34,770
08/23/2018 1,599   Disposition at $300.34 per share. 480,244
08/23/2018 827   48,619
03/27/2018 122   Derivative/Non-derivative trans. at $0 per share. 0
03/27/2018 350   Derivative/Non-derivative trans. at $0 per share. 0
02/11/2018 229   Derivative/Non-derivative trans. at $0 per share. 0
02/11/2018 662   Derivative/Non-derivative trans. at $0 per share. 0
02/05/2018 263   Derivative/Non-derivative trans. at $0 per share. 0
02/05/2018 679   Derivative/Non-derivative trans. at $0 per share. 0
02/11/2017 245   Derivative/Non-derivative trans. at $145.7 per share. 35,697
02/11/2017 662   Derivative/Non-derivative trans. at $0 per share. 0
02/05/2017 297   Derivative/Non-derivative trans. at $0 per share. 0
02/05/2017 679   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Mr. Vivek Jain
Chairman & Chief Executive Officer
Mr. Christian Voigtlander
Chief Operating Officer
Mr. Brian M. Bonnell
Chief Financial Officer & Treasurer
Mr. Krishna Uppugonduri
VP-Quality, Medical & Regulatory Affairs
Ms. Virginia Sanzone
Secretary, Vice President & General Counsel
Mr. Daniel Woolson
Vice President & General Manager-Infusion Systems
Dr. George A. Lopez
Director
Ms. Laurie Hernandez
Director
Mr. Thomas D. McCall
VP-Marketing & Communications, GM-Critical Care
Mr. Kevin J. McGrody
Chief Accounting Officer
Mr. Clay Fradd
Vice President-Human Resources
Mr. David C. Greenberg
Lead Independent Director
Ms. Elisha Wade Finney
Independent Director
Mr. Donald M. Abbey
Independent Director
Mr. David F. Hoffmeister
Independent Director
Dr. Robert S. Swinney
Independent Director
Trending Tickers
  • /zigman2/quotes/200172674/composite EDSA+102.72%
  • /zigman2/quotes/209901640/composite SPY-1.67%
  • /zigman2/quotes/201343976/composite UVXY+16.31%
  • /zigman2/quotes/221104327/composite LCID+4.83%
  • /zigman2/quotes/214109287/composite SDC-3.13%
X
Powered by StockTwits
Link to MarketWatch's Slice.